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This Month in the Journal
Glucosidase I Deﬁciency, by De Praeter et al.
(p. 1744)
De Praeter et al. present a neonate with a novel meta-
bolic disorder that is characterized by generalized hy-
potonia, hypomotility, dysmorphic features, and a fatal
outcome. On the basis of the accumulation of the N-
glycan fragment Glc(a1-2)Glc(a1-3)Glc(a1-3)Man of
glycoproteins in the patient’s urine, the authors postu-
late a defect in glucosidase I activity, which removes the
distal (a1-2)–linked glucose residue from N-linked
Glc3Man9GlcNAc2. Assays of glucosidase I in liver tissue
and skin ﬁbroblasts from the patient conﬁrmed this re-
duction in activity, whereas sequencing of the glucosi-
dase I locus identiﬁed the patient as a compound het-
erozygote, possessing an R486T mutation on one allele
and an F562L mutation on the other. Along with the
accumulation of Glc(a1-2)Glc(a1-3)Glc(a1-3), loss of
glucosidase I–cleavage activity leads to a deﬁciency in
the complex type N-linked glycans. Subsequently, there
is development of dilatation and ﬁbrosis of the bile ducts,
demyelinating polyneuropathy, and multilamellar inclu-
sions in the cytoplasm of parenchymal cells, in bile can-
aliculi, and in the bile-duct lumina. This work highlights
the fact that, despite the century of work since Sir Ar-
chibald Garrod recognized inborn errors of metabolism,
not all of these disorders have yet been recognized.
Origin and Phenotype of Triploidy, by Zaragova et al.
(p. 1807)
Triploidy is a relatively common cause of spontaneous
abortions, but the relationship between triploidy origin
and phenotype has thus far been unclear. Cytogenetic
studies indicate that most cases of triploidy have a pa-
ternal origin and that most of these paternally derived
cases are partial hydatidiform moles. Molecular studies
have come to a different conclusion—that is, that most
cases of triploidy are from a maternal origin. To resolve
these discrepancies, Zaragova et al. have used a com-
bination of molecular and histological techniques to
study the origins of triploidy and have found that the
disparate conclusions largely result from differences in
ascertainment criteria, since the origin of triploidy affects
phenotype. Although maternally derived triploids either
abort as young embryos (at !8.5 wk gestation) or survive
to form well-developed fetuses and then abort, pater-
nally derived cases of triploidy generally abort at an
intermediate time, at 10–20 wk gestation, and some-
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times are associated with the formation of partial hy-
datidiform moles. Since previous studies included sam-
ples of different gestational age and phenotype, it seems,
on the basis of the samples chosen, that there was in-
advertent selection for a particular triploidy origin.
Search for Type 2 Diabetes Genes, by Ehm et al.
(p. 1871)
In this multicenter, collaborative study, a sample of
1,783 individuals from four ethnic groups was examined
for evidence of linkage to type 2 diabetes. A full-genome
scan from the ﬁrst phase of this study provided signiﬁ-
cant evidence for type 2 diabetes loci on chromosomes
3 and 12, as well as suggestive evidence for loci on chro-
mosomes 5, 10, and X. Although some of these loci had
been implicated in other studies of type 2 diabetes, the
results generally were not replicated in the second phase
of this study. This lack of replication, even in such a
large and careful study, emphasizes the difﬁcult nature
of linkage studies of complex disorders, in which mu-
tations in several genes may lead to the same clinical
phenotype and in which the involved genes may vary
between ethnic groups. As linkage analysis for complex
disorders becomes increasingly prevalent, the question
is raised as to how future studies can be better designed,
to increase their effectiveness.
Genomic Differentiation of Neanderthals and
Humans, by Scholz et al. (p. 1927)
Through a Southern hybridization method that assesses
cross-hybridization of fossil DNA, Scholz et al. were able
to distinguish two well-deﬁned Neanderthal fossils from
that of a modern human. For this assay to measure hy-
bridization variation between the samples, signiﬁcant
differences in their genomes—most likely, within repet-
itive sequences—must be present. The results may be
used to argue that Neanderthals and modern humans
arose from separate lineages, but the rough nature of
the assay prevents conclusive results concerning phylo-
genetic relationships. Although this method does not al-
low researchers to study speciﬁc sequences, it may allow
classiﬁcation of fossils for which morphology studies
could not provide deﬁnitive results. Although the clas-
siﬁcation of these fossils is technically challenging, these
data are sure to be provocative.
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Report (Histone Acetylation in PWS), by Saitoh and
Wada (p. 1958)
The SNURF-SNRPN locus on chromosome 15q co-
localizes with an imprinted region that is important in
Prader-Willi syndrome (PWS), a neurogenetic disorder
characterized by obesity, mental retardation, and hy-
pogonadism. SNRPN encodes the small nuclear ribo-
nucleoprotein N, which is expressed predominantly in
the brain and central neurons and which is believed to
be involved in mRNA processing. Normally, only the
paternal SNRPN allele is expressed, and the maternal
allele is methylated and inactive. In individuals with
PWS, the paternal allele is either missing or defective,
and expression of this gene is therefore not detected.
Saitoh and Wada have examined the SNRPN locus to
understand the basis of imprinting, speciﬁcally the role
of acetylation in this process. They have found that, on
the inactive, maternal alleles of the SNRPN locus, the
CpG island is hypoacetylated. Increased acetylation and
expression of the maternal allele were induced through
demethylation of the DNA by 5-aza-dC. These results
indicate that methylation, acetylation, and gene expres-
sion are intertwined in the process of genomic imprint-
ing. Furthermore, these data suggest that demethylating
agents could be used to reactivate the maternal alleles
of this imprinted region.
Report (BRCA1 Founder Mutations in Poland), by
Go´rski et al. (p. 1963)
This study of Polish families affected by breast and ovar-
ian cancer has identiﬁed recurrent BRCA1 mutations in
this population, suggesting the presence of founder mu-
tations. Three recurrent mutations, 5382insC, C61G,
and 4153delA, constitute 82% of the BRCA1 mutations
recognized in this study. The identiﬁcation of recurrent
mutations in speciﬁc populations allows for more cost-
effective and rapid screening of individuals for BRCA1
mutations. This information is valuable not only for
families in Poland but also for families of Polish descent,
a substantial number of whom reside in North America.
KATHRYN BEAUREGARD
Editorial Fellow
